Clinical Trials
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients...
News
Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a...
News
BMG Pharma’s nasal spray, mouth rinse achieve efficacy in preventing COVID-19
Milan headquartered biopharmaceutical and B2B company BMG Pharma with its chemical plant in Torviscosa (Italy), conducted a clinical study with encouraging results to assess...
Press Releases
Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company and Canadian biotech firm SaNOtize Research & Development Corp. announced an exclusive long term strategic partnership...
Press Releases
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine (mRNA-1345)
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA as granted Fast Track designation for mRNA-1345,...
News
Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP
Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, announced that China Southern Airlines has approved the Envirotainer...
News
ACG Films and Foils and Danapak Flexibles A/S enters Strategic Partnership for India
ACG, one of world's most integrated pharmaceutical supplier, announced its strategic partnership with Danapak Flexibles A/S, the global market leader in packaging for high...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read